adenosine has been researched along with Cutaneous T-Cell Lymphoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, K; Hu, M; Jiang, X; Wang, X; Yu, L; Zhang, G | 1 |
1 other study(ies) available for adenosine and Cutaneous T-Cell Lymphoma
| Article | Year |
|---|---|
The "m6A writer" METTL3 and the "m6A reader" IGF2BP2 regulate cutaneous T-cell lymphomas progression via CDKN2A.
Topics: Adenosine; Cyclin-Dependent Kinase Inhibitor p16; Humans; Lymphoma, T-Cell, Cutaneous; Methyltransferases; RNA-Binding Proteins; RNA, Messenger | 2022 |